Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991–2019
Malaria Journal2020Vol. 19(1), pp. 374–374
Citations Over TimeTop 10% of 2020 papers
Giulia Rathmes, Susan F. Rumisha, Tim Lucas, Katherine A. Twohig, André Python, Huong Lan Thi Nguyen, A. Nandi, Suzanne Keddie, Emma L. Collins, Jennifer Rozier, Harry S. Gibson, Elisabeth G. Chestnutt, Katherine E. Battle, Georgina Humphreys, Punam Amratia, Rohan Arambepola, Amelia Bertozzi-Villa, Penelope A. Hancock, Justin Millar, Tasmin L. Symons, Samir Bhatt, Ewan Cameron, Philippe J. Guérin, Peter W. Gething, Daniel J. Weiss
Abstract
This study provides evidence that health system performance, drug quality and patient adherence influence the effectiveness of anti-malarials used in treating uncomplicated falciparum malaria. These results provide guidance to countries' treatment practises and are critical inputs for malaria prevalence and incidence models used to estimate national level malaria burden.
Related Papers
- → Enhancing the antimalarial activity of artesunate(2020)70 cited
- → Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine(2002)23 cited
- → The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria(2009)13 cited
- → Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria(1992)159 cited
- Efficacy and effectiveness of five day treatment of uncomplicated falciparum with artemisinin or artesunate in Vietnam.(1999)